| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZBIO | Common Stock | Purchase | $269K | +25K | +14.61% | $10.76 | 196K | 03 Dec 2024 | Direct | F1 |
| transaction | ZBIO | Common Stock | Purchase | $449K | +45K | +22.94% | $9.98 | 241K | 04 Dec 2024 | Direct | F2 |
| holding | ZBIO | Common Stock | 1.67M | 03 Dec 2024 | See Footnote | F3 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $10.73 to $10.88, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| F2 | The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $9.81 to $10.26, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| F3 | Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |